辽宁:3111家医药机构因违规使用医保基金被处理

2019-03-01 彭卓 新华社

辽宁省医保局近日宣布,全省3111家定点医药机构因违规使用医保基金,被予以解除定点协议、暂停医保服务等处理。据辽宁省医保局介绍,2018年底以来,辽宁在全省范围内开展了打击医疗保险欺诈骗保专项行动。有关部门整合医保、卫健、公安、审计、药监等多部门力量,共成立100多个联合检查组,出动万余人次进行现场检查,运用大数据分析和智能监控手段进行筛查,并对重复住院、雷同病例等疑点信息进行重点筛查。经筛查发现

辽宁省医保局近日宣布,全省3111家定点医药机构因违规使用医保基金,被予以解除定点协议、暂停医保服务等处理。

据辽宁省医保局介绍,2018年底以来,辽宁在全省范围内开展了打击医疗保险欺诈骗保专项行动。有关部门整合医保、卫健、公安、审计、药监等多部门力量,共成立100多个联合检查组,出动万余人次进行现场检查,运用大数据分析和智能监控手段进行筛查,并对重复住院、雷同病例等疑点信息进行重点筛查。

经筛查发现,违规医药卫生机构主要有人为降低住院标准、定点药店医保套现、刷卡售卖非医药用品等违法违规行为。辽宁全省共处理定点医疗机构违规1254家、定点零售药店1857家。按照情节严重程度,违规医药机构被分别处以移交公安机关侦查、解除定点协议、暂停医保服务、行政处罚、通报批评、约谈限期整改等处理。

辽宁省医保局表示,辽宁还将继续开展医疗保险违法违规警示教育,提高医药从业人员遵纪守法的自觉性,并提高宣传力度,引导参保人员合理就医、规范购药。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719707, encodeId=f1501e19707bc, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Wed Mar 27 22:41:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747737, encodeId=8bfb1e4773717, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Tue Jun 11 16:41:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409805, encodeId=4dfe140980512, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435008, encodeId=5aa71435008a9, content=<a href='/topic/show?id=ab323383457' target=_blank style='color:#2F92EE;'>#医保基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33834, encryptionId=ab323383457, topicName=医保基金)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361796, encodeId=4336361e963d, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Mar 01 21:44:12 CST 2019, time=2019-03-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1719707, encodeId=f1501e19707bc, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Wed Mar 27 22:41:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747737, encodeId=8bfb1e4773717, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Tue Jun 11 16:41:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409805, encodeId=4dfe140980512, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435008, encodeId=5aa71435008a9, content=<a href='/topic/show?id=ab323383457' target=_blank style='color:#2F92EE;'>#医保基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33834, encryptionId=ab323383457, topicName=医保基金)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361796, encodeId=4336361e963d, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Mar 01 21:44:12 CST 2019, time=2019-03-01, status=1, ipAttribution=)]
    2019-06-11 zhao4628
  3. [GetPortalCommentsPageByObjectIdResponse(id=1719707, encodeId=f1501e19707bc, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Wed Mar 27 22:41:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747737, encodeId=8bfb1e4773717, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Tue Jun 11 16:41:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409805, encodeId=4dfe140980512, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435008, encodeId=5aa71435008a9, content=<a href='/topic/show?id=ab323383457' target=_blank style='color:#2F92EE;'>#医保基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33834, encryptionId=ab323383457, topicName=医保基金)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361796, encodeId=4336361e963d, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Mar 01 21:44:12 CST 2019, time=2019-03-01, status=1, ipAttribution=)]
    2019-03-03 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1719707, encodeId=f1501e19707bc, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Wed Mar 27 22:41:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747737, encodeId=8bfb1e4773717, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Tue Jun 11 16:41:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409805, encodeId=4dfe140980512, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435008, encodeId=5aa71435008a9, content=<a href='/topic/show?id=ab323383457' target=_blank style='color:#2F92EE;'>#医保基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33834, encryptionId=ab323383457, topicName=医保基金)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361796, encodeId=4336361e963d, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Mar 01 21:44:12 CST 2019, time=2019-03-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1719707, encodeId=f1501e19707bc, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Wed Mar 27 22:41:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747737, encodeId=8bfb1e4773717, content=<a href='/topic/show?id=528294510d4' target=_blank style='color:#2F92EE;'>#违规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94510, encryptionId=528294510d4, topicName=违规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe7b35947177, createdName=zhao4628, createdTime=Tue Jun 11 16:41:00 CST 2019, time=2019-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409805, encodeId=4dfe140980512, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435008, encodeId=5aa71435008a9, content=<a href='/topic/show?id=ab323383457' target=_blank style='color:#2F92EE;'>#医保基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33834, encryptionId=ab323383457, topicName=医保基金)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Mar 03 12:41:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361796, encodeId=4336361e963d, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Mar 01 21:44:12 CST 2019, time=2019-03-01, status=1, ipAttribution=)]
    2019-03-01 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

首创!福州医药机构医保定点实行备案管理

“医保定点管理模式变为备案管理,不再对已经相关行政主管部门批准设立的医药机构设置前置条件”

国家医保局:医药机构欺诈骗保将被解除定点协议

国家医保局日前印发《关于当前加强医保协议管理确保基金安全有关工作的通知》,要求各地医保经办机构加强对定点医药机构的协议管理,确保医保基金安全。